Axon Enterprise (NASDAQ:AXON) Insider Sells $800,000.00 in Stock

Axon Enterprise, Inc (NASDAQ:AXON) insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the sale, the insider directly owned 52,813 shares of the company’s stock, valued at $21,125,200. The trade was a 3.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Isaiah Fields also recently made the following trade(s):

• On Friday, February 27th, Isaiah Fields sold 2,000 shares of Axon Enterprise stock. The stock was sold at an average price of $535.01, for a total transaction of $1,070,020.00.

Axon Enterprise Stock Performance

Shares of AXON stock traded down $0.70 during midday trading on Tuesday, hitting $385.30. 1,295,994 shares of the company were exchanged, compared to its average volume of 1,074,651. The firm has a market capitalization of $31.06 billion, a P/E ratio of 154.74, a PEG ratio of 7.02 and a beta of 1.44. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The firm’s 50 day moving average price is $414.25 and its two-hundred day moving average price is $499.29. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.47 EPS. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $29,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $37,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $34,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $28,000. Finally, Sound Income Strategies LLC boosted its stake in shares of Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on AXON shares. UBS Group decreased their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a report on Thursday, May 7th. Royal Bank Of Canada decreased their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Finally, The Goldman Sachs Group set a $535.00 target price on shares of Axon Enterprise in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.